We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
🚨ZEPBOUND BECOMES FIRST FDA-APPROVED DRUG FOR SLEEP APNEA Eli Lilly's Zepbound has received FDA approval as the first drug specifically for treating obstructive sleep apnea in adults with obesity. This breakthrough could change how millions with sleep apnea are treated, offering an alternative to traditional CPAP machines and surgery. The drug, also known for weight loss, is already gaining traction and may expand its market significantly. Zepbound shows promising results in clinical trials, helping to alleviate symptoms in 52% of patients. Source: Reuters